Testing anti-cancer drugs in people age 65 and older
Part of Cancer clinical trials.
This study looks at how anti-cancer (chemotherapy) drugs are used in adults age 65+ who have cancer. It may help doctors understand which treatments work best and are safest for older adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 65 years old or older
- Have a confirmed cancer diagnosis
- Be currently using anti-cancer medicines (anti-neoplastic drugs)
- Not be expected to pass away within the next 48 hours
- Not have an allergy to anti-cancer medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with cancer who are receiving anti-cancer medicines that are being used “off-label” (not exactly as the usual label says). It aims to learn about how these treatments are used in real life and what outcomes people experience.
This trial tests approved cancer drugs in people aged 70 and older with non-small-cell lung cancer who haven't had systemic treatment before. The goal is to see how well these drugs work in this older population.
This trial is testing a combination of an oral chemotherapy pill (vinorelbine) and an immunotherapy drug (PD-1 inhibitor) for people aged 65 and older with advanced non-small cell lung cancer who have not had treatment before. The goal is to see if this approach can help control the cancer with fewer side effects.
This trial tests a combination of chemotherapy and immunotherapy followed by radiation for older adults with head and neck cancer. It aims to see if this approach is safe and effective for people aged 65 and older.
This trial tests whether early and personalized care from a geriatric specialist can improve cancer treatment for people aged 75 and older. It is for those starting a new cancer therapy, either for the first time or after a break of at least six months.
This trial looks at aging-related changes in older adults (70+) with early-stage lung cancer who are planning to have surgery. The goal is to better understand how these changes might affect recovery and outcomes, which could help improve care for future patients.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.